Ecstasy, legal highs and designer drug use: A Canadian perspective

  title={Ecstasy, legal highs and designer drug use: A Canadian perspective},
  author={Alan L. Hudson and Maggie D. Lalies and Glen B. Baker and Kristopher Wells and Katherine J. Aitchison},
  journal={Drug Science, Policy and Law},
Recreational drug use in Canada is not uncommon, but as with most societies, illegal drug use carries harsh penalties resulting in a criminal record when an individual is successfully prosecuted. Popular drugs of use in Canada include ecstasy, cannabis (including some synthetic cannabinoids sold as ‘Spice’ and ‘Incense’) and several emerging psychoactive ‘legal highs’. Surprisingly, Canada is a major manufacturer and exporter of the popular club drug ecstasy, with criminal gangs organising the… 

Figures from this paper

MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
Infrequent dosing of MDMA mitigates adverse event frequency and improves the risk/benefit ratio of MDMA, which may provide a significant advantage over medications that require daily dosing.
Potentiel criminalistique de l'étude du trafic de drogues au Canada à partir des données collectées sur les cryptomarchés
ABSTRACT Cryptomarkets represent a new innovation for illegal goods trafficking, where drugs are predominantly found. After an overview of the features these sites offer, to understand the virtual
Systematic analysis of novel psychoactive substances. I. Development of a compound database and HRMS spectral library
Abstract With the rise in illicit use of novel psychoactive substances (NPS), there is a need to comprehensively screen for drugs in this class. In the present project to explore the screening


Qualitative Review of Serotonin Syndrome, Ecstasy (MDMA) and the use of Other Serotonergic Substances: Hierarchy of Risk
The study aimed to synthesize the risk of serotonin syndrome associated with the concomitant use of ecstasy and other serotonergic substances in a clinically relevant hierarchy for psychiatrists and other medical practitioners.
Perverse effects of the precautionary principle: how banning mephedrone has unexpected implications for pharmaceutical discovery
  • D. Nutt
  • Medicine, Psychology
    Therapeutic advances in psychopharmacology
  • 2011
Last year saw the banning of several new synthetic stimulant drugs and many of their analogues, but it now seems that mephedrone was probably one of the least harmful stimulants, being less potent than most alternatives.
Ecstasy (MDMA): a review of its possible persistent psychological effects
  • M. Morgan
  • Psychology, Medicine
  • 2000
There is growing evidence that chronic, heavy, recreational use of ecstasy is associated with sleep disorders, depressed mood, persistent elevation of anxiety, impulsiveness and hostility, and selective impairment of episodic memory, working memory and attention.
Agony and ecstasy: a review of MDMA effects and toxicity
Ecstasy toxicity should be considered in the differential diagnosis of a variety of medical and psychiatric conditions and both the acute and the potential long-term effects are a cause for concern.
Clinical toxicology of newer recreational drugs
The available information on newer synthetic stimulant, entactogenic and hallucinogenic drugs are reviewed, a framework for classification of these drugs based on chemical structure is provided and their pharmacology and clinical toxicology are described.
Effects of Schedule I drug laws on neuroscience research and treatment innovation
An important and unfortunate outcome of the controls placed on these and other psychoactive drugs is that they make research into their mechanisms of action and potential therapeutic uses difficult and in many cases almost impossible.
Recreational bupropion abuse in a teenager.
  • J. McCormick
  • Medicine
    British journal of clinical pharmacology
  • 2002
A 13-year old Caucasian girl with a past history of deliberate illicit drug ingestion and evidence of a conduct disorder and mood upset symptoms was admitted to the paediatric ward after intentionally swallowing four bupropion tablets that were supplied by a friend.
Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms
The evidence documenting the adverse effects of the MDMA (MDMA, Ecstasy) drug in some animal models is reviewed and possible mechanisms for the development of MDMA neurotoxicity are discussed.
Cathinone derivatives: a review of their chemistry, pharmacology and toxicology.
  • J. Kelly
  • Chemistry, Medicine
    Drug testing and analysis
  • 2011
It can be assumed that, despite their illegal status, cathinone-related compounds will continue to be prevalent drugs of abuse for the foreseeable future.
Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States
The emergence of a new group of substances of abuse in the USA, known as bath salts, is reported with quantitative results in 18 patients, the first report of MDPV exposures with quantitative blood level confirmation.